Corix Bioscience, Inc.
CXBS
$0.00
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 09/30/2016 | ||
|---|---|---|---|---|---|
| Net Income | -3.14M | -1.18M | -1.18M | -1.55M | |
| Total Depreciation and Amortization | 3.80K | -- | -- | 400.00 | |
| Total Amortization of Deferred Charges | 231.50K | 9.30K | 9.30K | -- | |
| Total Other Non-Cash Items | 2.89M | 258.90K | 258.90K | 992.10K | |
| Change in Net Operating Assets | -1.71M | 382.10K | 382.10K | -6.30K | |
| Cash from Operations | -1.72M | -531.10K | -531.10K | -561.90K | |
| Capital Expenditure | -81.60K | -- | -- | -5.10K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | 0.00 | 60.20K | 60.20K | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 3.47M | 479.90K | 479.90K | -9.40K | |
| Cash from Investing | 3.39M | 540.10K | 540.10K | -14.50K | |
| Total Debt Issued | 164.80K | 144.00K | 144.00K | 167.30K | |
| Total Debt Repaid | -163.80K | -71.60K | -71.60K | -- | |
| Issuance of Common Stock | 400.00 | 66.70K | 66.70K | 509.60K | |
| Repurchase of Common Stock | -155.90K | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -1.29M | -16.70K | -16.70K | -18.30K | |
| Cash from Financing | -1.45M | 122.30K | 122.30K | 658.60K | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 216.40K | 131.40K | 131.40K | 82.20K | |